查詢結果分析
相關文獻
- 咳嗽治療的實證研究
- 呼吸困難及咳嗽
- 慢性咳嗽與慢性阻塞性肺病之鑑別診斷
- Chronic Obstructive Pulmonary Disease Assessment Test (CAT) Correlated Well with Modified Medical Research Council (mMRC) Dyspnea Scale
- 慢性阻塞性肺病反覆咳嗽以六君子湯等複方治療驗案
- Chinese Medicine Ameliorates Cough after Receiving Oxford AstraZeneca COVID-19 Vaccine: A Case Report
- COVID-19確診後久咳不癒之病例報告
- 中醫藥改善卵巢癌患者術後眠差併新冠肺炎咳嗽之病例報告
- 咳嗽、發燒、血痰、呼吸困難
- 皮下腫瘤、咳嗽、呼吸困難、全身浮腫
頁籤選單縮合
| 題 名 | 咳嗽治療的實證研究=Treatment of Cough: Evidence-Based Research |
|---|---|
| 作 者 | 林展弘; | 書刊名 | 臺北市中醫醫學雜誌 |
| 卷 期 | 31:1=107 2025.03[民114.03] |
| 頁 次 | 頁25-31 |
| 分類號 | 413.341 |
| 關鍵詞 | 新冠肺炎; 新冠止咳一號; 咳嗽; 慢性阻塞性肺病; 呼吸困難; COVID-19; COVID-19 cough relief formula No. 1; Cough; Chronic obstructive pulmonary disease; Dyspnea; |
| 語 文 | 中文(Chinese) |
| DOI | 10.6718/TJCM.202503_31(1).0004 |
| 中文摘要 | 新冠肺炎疫情對人們健康造成衝擊,許多康復的病患仍有咳嗽後遺症。研擬咳嗽專 方-新冠止咳一號,治療新冠肺炎確診者轉陰起算 1 個月內,見乾咳、咽喉不適、胸悶、 鼻塞、流涕等症狀與倦怠感者。 本研究收錄病患在治療前後使用呼吸困難量表 mMRC、自我評量表 Borg Scale 和慢 性阻塞性肺病量表的 CAT 進行症狀評估。 依據 CAT 量表總分,病患被劃分為輕度和中度兩組。臨床治療收錄病患的數據包含 從一次到四次不等的症狀評估,提供了多時點的病患症狀變化資訊。經過臨床統計顯示 咳嗽專方-新冠止咳一號對病患的咳嗽頻率和痰量多寡,在輕度和重度病患的改善率展 現顯著效果,這項研究為新冠肺炎後期病患的咳嗽治療提供一個有希望的選擇。 |
| 英文摘要 | The COVID-19 pandemic has had a significant impact on people's health, with many patients suffering from lingering symptoms such as cough. A specialized treatment, "COVID-19 Cough Relief Formula No. 1," has been developed to treat individuals within one month of testing negative after being diagnosed with COVID-19 and who are experiencing symptoms like dry cough, throat discomfort, chest tightness, nasal congestion, runny nose, and fatigue. This study included patients who were assessed using the mMRC (Modified Medical Research Council) dyspnea scale, the Borg Scale for self-assessment, and the CAT (Chronic Obstructive Pulmonary Disease Assessment Test) scale before and after treatment to evaluate symptoms. Based on the total score from the CAT scale, patients were categorized into mild and moderate groups. Clinical treatment data included symptom assessments conducted from one to four times, providing information on changes in patient symptoms over multiple clinical visits. Statistical analysis showed that the COVID-19 Cough Relief Formula No. 1 significantly improved the frequency of coughing and the amount of sputum in both mild and severe patients. This study provides a promising treatment option for patients with post-COVID-19 cough. |
本系統中英文摘要資訊取自各篇刊載內容。